Our nationally and internationally recognized specialists offer comprehensive evaluation, diagnosis and treatment for patients who have diseases that affect the lungs and breathing.
Our doctors are board-certified in internal medicine, pulmonary medicine, critical care and sleep medicine. We also have physicians who specialize in interventional pulmonary medicine. Our physicians work closely with colleagues in cardiothoracic surgery, diagnostic radiology, and pathology to provide comprehensive care. In the sleep centers, sleep specialists treat all varieties of sleep disorders.
We treat patients in a large outpatient program in the Winchester Center for Lung Disease and through hospital inpatient and primary care services. Specialized physicians staff Yale's critical care services 24/7, and offer state-of-the-art critical care interventions. Winchester Center for Lung Disease is adjacent to a state-of-the-art Pulmonary Function Laboratory.
Specialized care is offered in the following areas:
Adult cystic fibrosis
Asthma and airway diseases
Bronchiectasis and chronic pulmonary infections
Cardiorespiratory exercise testing
Chronic obstructive pulmonary disease (COPD)
Clinical research in all lung diseases
Interstitial lung disease
Lung cancer screening and pulmonary nodule evaluation
Medical intensive care unit
Multidisciplinary sleep care
Pulmonary function laboratory
Pulmonary vascular disease
Sleep apnea and other sleep disorders
Thoracic interventional pulmonary embolism
Our center for pulmonary medicine (P2MED) focuses on developing methods to apply precision medicine approaches to chronic lung disease.
Our Interstitial Lung Disease Center is a Pulmonary Fibrosis Foundation-recognized clinical care center, one of the first nine in the United States.
Our Thoracic Interventional Program offers the most advanced diagnostic and therapeutic approaches to diseases of the chest, including lung nodules and masses, enlarged lymph nodes, complex airways, and pleural effusions.
Our Pulmonary Vascular Disease Program is recognized by PH and Scleroderma Foundation.
We conduct clinical trials and observational studies in asthma, idiopathic pulmonary fibrosis, pulmonary hypertension, and sarcoidosis.
We have support groups and outreach activities for idiopathic pulmonary fibrosis and cystic fibrosis.